YSM Moves Up to 3rd in US for NIH Funding Yale School of Medicine Nawigacja wpisu Epigenetic editing of PCSK9 for a durable reduction in cholesterol – Nature.com Shifting the Patient-Provider Care Paradigm – Flathead Beacon
